1. Home
  2. COLL vs BBSI Comparison

COLL vs BBSI Comparison

Compare COLL & BBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • BBSI
  • Stock Information
  • Founded
  • COLL 2002
  • BBSI 1965
  • Country
  • COLL United States
  • BBSI United States
  • Employees
  • COLL N/A
  • BBSI N/A
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • BBSI Professional Services
  • Sector
  • COLL Health Care
  • BBSI Consumer Discretionary
  • Exchange
  • COLL Nasdaq
  • BBSI Nasdaq
  • Market Cap
  • COLL 910.2M
  • BBSI 1.1B
  • IPO Year
  • COLL 2015
  • BBSI 1993
  • Fundamental
  • Price
  • COLL $29.71
  • BBSI $41.21
  • Analyst Decision
  • COLL Strong Buy
  • BBSI Buy
  • Analyst Count
  • COLL 5
  • BBSI 3
  • Target Price
  • COLL $43.60
  • BBSI $41.67
  • AVG Volume (30 Days)
  • COLL 466.9K
  • BBSI 136.3K
  • Earning Date
  • COLL 05-08-2025
  • BBSI 04-30-2025
  • Dividend Yield
  • COLL N/A
  • BBSI 0.77%
  • EPS Growth
  • COLL 43.56
  • BBSI 7.03
  • EPS
  • COLL 1.86
  • BBSI 1.98
  • Revenue
  • COLL $631,449,000.00
  • BBSI $1,144,531,000.00
  • Revenue This Year
  • COLL $19.43
  • BBSI $9.65
  • Revenue Next Year
  • COLL $3.34
  • BBSI $7.57
  • P/E Ratio
  • COLL $16.00
  • BBSI $21.12
  • Revenue Growth
  • COLL 11.41
  • BBSI 7.04
  • 52 Week Low
  • COLL $27.28
  • BBSI $28.42
  • 52 Week High
  • COLL $42.29
  • BBSI $44.97
  • Technical
  • Relative Strength Index (RSI)
  • COLL 48.90
  • BBSI 53.35
  • Support Level
  • COLL $29.33
  • BBSI $40.77
  • Resistance Level
  • COLL $30.84
  • BBSI $42.28
  • Average True Range (ATR)
  • COLL 0.85
  • BBSI 0.81
  • MACD
  • COLL 0.08
  • BBSI 0.27
  • Stochastic Oscillator
  • COLL 50.11
  • BBSI 69.08

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.

Share on Social Networks: